Article -> Article Details
Title | Viral Gastroenteritis Market Emerging Technologies by Industry Size |
---|---|
Category | Fitness Health --> Family Health |
Meta Keywords | Viral Gastroenteritis Market |
Owner | vinit |
Description | |
According to a report by Market Research future (MRFR), the
global viral
gastroenteritis market is expected to register a remarkable
market valuation at 7.5% CAGR over the evaluation period. The impactful factors influencing the growth of the global
viral gastroenteritis market during the forecast period are growing prevalence
of gastrointestinal diseases, accessibility of cost-effective treatment, and
the extensive research and development activities towards internal medicine.
Additionally, there is a growing demand for the introduction of new drugs for
the treatment of viral gastroenteritis. The severely competitive market scenario is expected to act
as a substantial barrier for new entrants in the global viral gastroenteritis
market over the review period. Segmental Analysis The global viral gastroenteritis market is segmented on the
basis of the type of virus, diagnosis, drug, indication, and end-user. Based on the type of virus, the viral gastroenteritis market
has been segmented into astrovirus, enteric adenovirus, norovirus, and
rotavirus. On the basis of diagnosis, the global viral gastroenteritis
market has been segmented into the physical examination and rapid stool tests. Based on the indication, the global viral gastroenteritis
market has been segmented into antacids, antibiotics, antimotility agents,
laxatives, and others. Based on end-user, the global viral gastroenteritis market
is segmented into ambulatory care centers, clinics, diagnostic centers,
hospitals, pharmaceutical companies. Regional Analysis Based on the region, the market has been segmented into the
Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas account for the largest region in the global
viral gastroenteritis market and are expected to retain the significant market
share over the evaluation period. This is attributable to the rising prevalence
of viral gastroenteritis in the region, along with the presence of a key market
player in developed countries such as the US and Canada. The Asia Pacific is accounted for the fastest growing region
over the forecast period. The significant growth of the Asia Pacific region is
credited to the increasing expenditure of the governments towards the
improvement of the healthcare sector in developing countries such as India and
China. Additionally, the growing prevalence of chronic diseases has led to an
increasing demand for technologically advanced treatment and diagnostic
measures, which is expected to consequently drive the market growth in the
region over the review period. The middle east and Africa region accounts for the smallest
market share in the global viral gastroenteritis market over the forecast
period, owing to the poor healthcare sector and weak economic growth in Africa.
Additionally, the political unrest in a particular part of Africa and the
middle east is also expected to slow the growth of the market in the region.
The government efforts towards the improvement of the healthcare sector have
risen expenditure, research and development activities and the presence of
global nonprofit organizations in the region, which is likely to contribute
significantly to the viral gastroenteritis market in Africa over the forecast
period. Moreover, the developing countries of the Middle East such as the United
Arab Emirates, Saudi Arabia,Kuwait and Turkey with improving healthcare
infrastructure, are expected to contribute to the majority of the market share
over the assessment period Key Players the key players in the global viral gastroenteritis market
are Abbott (U.S.), Allergan (Ireland), AstraZeneca (U.K), Bayer AG (Germany),
GlaxoSmithKline (U.S.), Janssen Global Services, LLC U.S.), Sanofi (France),
Takeda Pharmaceutical (Japan), and Valeant Pharmaceuticals International Inc.
(U.S.). |